Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure
Microbiology Spectrum · 14.02.2023 · 11 (1)
DOI: 10.1128/spectrum.02647-22 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 14.02.2023. Verfasst von Nicholas Rebold und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Carbapenems, Enterobacteriaceae Infections. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
This work compares carbapenem-resistant Enterobacterales (CRE) infections using patient, clinical, and treatment variables to understand which characteristics are associated with the highest risk of clinical failure. Knowing which risk factors are associated with CRE infection failure can provide clinicians better prognostic and targeted interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
- Anti-Infective Research Laboratory, Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
- Department of Pharmacy, Henry Ford Hospital, Henry Ford Health System, Detroit, Michigan, USA.
- Detroit Receiving Hospital, Detroit Medical Center, Detroit, Michigan, USA.
- School of Medicine, Wayne State University, Detroit, Michigan, USA.
ORCID-Profile: Nicholas Rebold, Ashlan J Kunz Coyne, Michael P Veve, Michael J Rybak
Förderung
- NIAID NIH HHS
Zitieren
APA
Rebold, N., Lagnf, A. M., Alosaimy, S., Holger, D. J., Witucki, P., Mannino, A., Dierker, M., Lucas, K., Kunz Coyne, A. J., El Ghali, A., Caniff, K. E., Veve, M. P., & Rybak, M. J. (2023). Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum, 11(1). https://doi.org/10.1128/spectrum.02647-22
Vancouver
Rebold N, Lagnf AM, Alosaimy S, Holger DJ, Witucki P, Mannino A, et al. Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum. 2023;11(1). doi:10.1128/spectrum.02647-22
BibTeX
@article{Rebold2023,
author = {Rebold, Nicholas and Lagnf, Abdalhamid M and Alosaimy, Sara and Holger, Dana J and Witucki, Paige and Mannino, Andrew and Dierker, Michelle and Lucas, Kristen and Kunz Coyne, Ashlan J and El Ghali, Amer and Caniff, Kaylee E and Veve, Michael P and Rybak, Michael J},
title = {Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure},
journal = {Microbiology Spectrum},
year = {2023},
volume = {11},
number = {1},
doi = {10.1128/spectrum.02647-22}
}
EUVIMED